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We report the case of a 29-year-old woman, working
as a nurse, who underwent a blood analysis to mon-
itor hypothyroidism. In addition to the ‘‘classical’’
parameters, her physician ordered a parathormone
(PTH) determination. The result of the PTH test was
found to be)2000 pg/mL (normal range: 12–54 pg/mL)
with the Liaison analyser (Diasorin, Stillwater, MN,
USA). As recently published (1), we considered this
result as ‘‘spurious’’ and we treated the sample with
HBR 1 (Scantibodies, Santee, CA, USA) and
RF-Absorbent (IBL, Hamburg, Germany) to remove a
possible interference due to human anti-animal anti-
bodies (HAAA) and rheumatoid factor (RF), respec-
tively. We also determined PTH with another method
(Roche Elecsys, Mannheim, Germany). We observed
that the result remained unchanged after HBR treat-
ment, whereas PTH dramatically fell to 40 pg/mL after
anti-RF treatment. With the Elecsys analyser, the PTH
was also normal (24 pg/mL). We thus suspected an
interference due to RF, but the patient neither suffered
from rheumatoid arthritis (and other autoimmune dis-
eases), nor was positive when we tested for RF (BN2,
Siemens, Marburg, Germany). To explore the cause
of this interference with the Liaison analyser, we then
performed a chromatographic separation with a
Superdex 200 HR 10/30 column (Amersham Biosci-
ences, Piscataway, NJ, USA) and we concluded that
there was PTH reactivity in the fraction that corre-
sponded to the molecular weight of the IgGs. This
confirmed the results of the RF-Absorbent treatment,
which, indeed, is a treatment of the sample with anti-
IgG antibody.
As the antibodies used for the PTH Liaison analyser
are polyclonal goat antibodies (whereas Roche Elec-
sys use monoclonal mouse antibodies), we suspected
that there was anti-goat IgG present in the serum of
the patient that could interfere with the assay. To con-
firm this hypothesis, we incubated 400 mL of the
patient’s serum with 40 mL of goat serum. In this con-
dition, we observed that PTH dropped from)2000 to
41 pg/mL.
Human anti-animal antibodies are a known cause
of interferences in immunoassays (2). This patient
had no obvious reason to present anti-goat antibodies
(any animal contact, professional exposition, coeliac
disease, drug, vaccination or blood transfusion). She
did not eat goat’s cheese or drink milk. A possible
cause could be a pregnancy 3 years prior, even if she
was primiparous (3). Even if the manufacturers
include in the inserts of the kits that this type of inter-
ference remains possible, one should be careful when
interpreting the results of any immunoassay. We
must keep in mind the tragic outcomes that can be
observed with these interferences (4). Indeed, these
antibodies can give spurious results, leading to
unnecessary cost-effective and stressful extra
investigations.
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